Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given written agreement to take part in the study.
- People aged 18 or older.
- People who have been assessed as needing mitral valve surgery (either repair or replacement), with or without a procedure to close a small pouch in the heart called the left atrial appendage.
- People who have had a confirmed diagnosis of a heart rhythm condition called atrial fibrillation (where the heart beats irregularly) — either in episodes or continuously — for at least 3 months before surgery, not caused by a short-term illness.
Who may not be able to join:
- People who have not given written agreement to take part.
- People who do not meet the inclusion criteria listed above.
- People for whom a freezing-based heart tissue treatment (cryoablation) is medically unsuitable (confirm with trial site).
- People who are currently breastfeeding, pregnant, or planning to become pregnant within 6 months of receiving the study treatment.
- People who have certain other health conditions that may themselves cause atrial fibrillation, such as an uncontrolled thyroid disorder, a serious active infection, a specific type of adrenal gland tumour, or a significant imbalance of minerals in the blood.
- People who have significant calcium build-up in a specific chamber of the heart (the left atrium).
- People who have previously had heart surgery.
- People whose heart's left atrium is very enlarged — measuring more than 10 cm in any direction on an ultrasound scan of the heart.
- People who are currently taking part in another clinical trial.
- People who are currently receiving a type of treatment called active biological therapy.
- People who need emergency surgery.
- People whose life expectancy is less than 12 months.
- People where, in the trial doctor's judgement, participation would carry unreasonable risk or make it difficult to follow the study procedures.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tomasz Hrapkowicz, MD PhD, Silesian Centre for Heart Diseases
Phone: +48-519-136-533
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of patients with no documented recurrence of atrial fibrillation on continuous 48h Holter ECG recording during 6-month follow-up.; Incidence of adverse events and serious adverse events related to the use of the
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.